PT-141 is a synthetic melanocortin receptor agonist peptide analog referenced in preclinical research literature for its receptor-binding profile and structural stability. It is supplied as a precisely characterized peptide compound for controlled laboratory investigation.
| Compound Name | PT-141 10mg |
| CAS Number | 189691-06-3 |
| Formula | C₅₀H₆₈N₁₄O₁₀ |
| Mol. Weight | 1025.18 g/mol |
| Structure | Synthetic Cyclic Heptapeptide Analog |
| Purity | ≥99% (HPLC verified) |
N-acetylated Nle with cyclic lactam bridge between Asp and Lys · D-Phe substitution at position 4 · Verified by mass spectrometry · Each batch tested to ≥99% purity by HPLC
| Property | Value |
|---|---|
| Compound Name | PT-141 10mg |
| Synonyms | PT-141; Bremelanotide; Melanocortin Receptor Agonist Analog |
| CAS Number | 189691-06-3 |
| Molecular Formula | C₅₀H₆₈N₁₄O₁₀ |
| Molecular Weight | 1025.18 g/mol |
| Structure Type | Synthetic Cyclic Heptapeptide Analog |
| Amino Acid Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂ |
| Bond Type | Cyclic peptide; lactam bridge Asp–Lys; N-terminal Ac-Nle; C-terminal amide (NH₂) |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Quantity | 10 mg per vial |
| Appearance | White to off-white powder |
| Solubility | Soluble in water or dilute acetic acid |
| Storage | -20°C, desiccated, protected from light |
| Shelf Life | 24 months |
| Country of Origin | United States |
| Intended Use | Research purposes only |
| Attribute | Details |
|---|---|
| SKU | CBL-PT141-10 |
| Category | Peptides |
| Documentation | Batch-specific COA available on request |
| Testing Method | HPLC with UV detection; MS confirmation available |
| Regulatory Status | Research Use Only. Not for human or veterinary administration. |
Your cart is empty
